Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-31 10:50 am Purchase |
2025-03-31 | 13D | Silence Therapeutics plc SLN |
Griffiths Richard Ian | 29,283,897 20.700% |
2,017,896 (+7.40%) |
Filing History |
| 2025-02-14 8:03 pm Purchase |
2024-12-31 | 13G | Silence Therapeutics plc SLN |
Redmile Group LLC | 7,197,951 5.100% |
7,197,951 (New Position) |
Filing History |
| 2025-02-11 6:41 pm Purchase |
2024-12-31 | 13G | Silence Therapeutics plc SLN |
Lombard Odier Asset Management (USA) Corp | 10,713,627 7.600% |
2,721,396 (+34.05%) |
Filing History |
| 2024-12-20 5:32 pm Purchase |
2024-12-18 | 13D | Silence Therapeutics plc SLN |
Griffiths Richard Ian | 27,266,001 19.300% |
3,556,899 (+15.00%) |
Filing History |
| 2024-11-14 1:13 pm Sale |
2024-09-30 | 13G | Silence Therapeutics plc SLN |
Lombard Odier Asset Management (USA) Corp | 7,992,231 5.700% |
-3,645,288 (-31.32%) |
Filing History |
| 2024-11-14 09:44 am Sale |
2024-09-30 | 13G | Silence Therapeutics plc SLN |
Deep Track Capital, LP | 3,000,000 2.140% |
-2,854,740 (-48.76%) |
Filing History |
| 2024-11-12 4:31 pm Purchase |
2024-09-30 | 13G | Silence Therapeutics plc SLN |
Invus Public Equities, L.P. | 8,495,310 6.100% |
156,453 (+1.88%) |
Filing History |
| 2024-08-02 6:51 pm Purchase |
2024-07-25 | 13G | Silence Therapeutics plc SLN |
Invus Public Equities, L.P. | 8,338,857 6.000% |
8,338,857 (New Position) |
Filing History |
| 2024-03-27 5:07 pm Sale |
2024-03-27 | 13D | Silence Therapeutics plc SLN |
Griffiths Richard Ian | 23,709,102 16.900% |
-5,013,153 (-17.45%) |
Filing History |
| 2024-02-14 09:54 am Purchase |
2023-12-31 | 13G | Silence Therapeutics plc SLN |
Lombard Odier Asset Management (USA) Corp | 11,637,519 10.400% |
10,317 (+0.09%) |
Filing History |
| 2024-02-14 08:55 am Unchanged |
2023-12-31 | 13G | Silence Therapeutics plc SLN |
Deep Track Capital, LP | 5,854,740 5.430% |
0 (Unchanged) |
Filing History |
| 2024-02-12 6:15 pm Sale |
2023-12-29 | 13G | Silence Therapeutics plc SLN |
GOLDMAN SACHS GROUP INC GS |
2,316,169 2.200% |
-2,224,994 (-49.00%) |
Filing History |
| 2024-02-09 5:05 pm Purchase |
2023-12-31 | 13G | Silence Therapeutics plc SLN |
Artal Participations S.a r.l | 9,000,000 7.800% |
1,500,000 (+20.00%) |
Filing History |
| 2023-09-01 4:12 pm Purchase |
2023-08-24 | 13G | Silence Therapeutics plc SLN |
Artal Participations S.a r.l | 7,500,000 6.800% |
7,500,000 (New Position) |
Filing History |
| 2023-08-14 5:01 pm Purchase |
2023-08-14 | 13D | Silence Therapeutics plc SLN |
Griffiths Richard Ian | 28,722,255 26.580% |
1,348,863 (+4.93%) |
Filing History |
| 2023-02-14 2:23 pm Purchase |
2022-12-31 | 13G | Silence Therapeutics plc SLN |
TCG Crossover GP I, LLC | 6,314,625 5.900% |
6,314,625 (New Position) |
Filing History |
| 2023-02-14 10:45 am Purchase |
2022-12-31 | 13G | Silence Therapeutics plc SLN |
Lombard Odier Asset Management (USA) Corp | 11,627,202 10.800% |
1,209,639 (+11.61%) |
Filing History |
| 2023-02-08 3:09 pm Purchase |
2022-12-30 | 13G | Silence Therapeutics plc SLN |
GOLDMAN SACHS GROUP INC GS |
4,541,163 5.100% |
4,541,163 (New Position) |
Filing History |
| 2022-10-20 4:01 pm Purchase |
2022-08-16 | 13D | Silence Therapeutics plc SLN |
Griffiths Richard Ian | 27,373,392 25.420% |
1,904,121 (+7.48%) |
Filing History |
| 2022-08-22 4:13 pm Purchase |
2022-08-12 | 13G | Silence Therapeutics plc SLN |
Deep Track Capital, LP | 5,854,740 5.440% |
5,854,740 (New Position) |
Filing History |